TRPV1 Knockout Cell Line-293T : 1x10^6 Cellule/vial; 1mL

The TRPV1 Knockout Cell Line (293T) is a genetically engineered human embryonic kidney (HEK 293T) cell line with the TRPV1 (Transient Receptor Potential Vanilloid 1) gene knocked out using advanced CRISPR/Cas9 technology. This knockout model is ideal for studying pain signaling, neurotransmission, ion channel regulation, and drug screening targeting TRPV1-related pathways.

Supplied as 1×10⁶ viable cells per vial (1 mL), this line provides a reliable system for in vitro assays, pharmacological testing, and functional validation of TRPV1-independent mechanisms.